Prices delayed by at least 15 minutes | Print


Faron Pharmaceuticals Oy (FARN)

ORD NPV (DI)
Sell: 135p|Buy: 140p|Change: 2.50 (-1.79%)

Open 

140p


Previous close 

140p


Trade high 

145p


Volume 

40,251


Year high 

370.00p


Year low 

120.00p


Dividend yield 

-


Market capitalisation 

£94.61 mn


P/E ratio 

-


ISIN 

FI4000153309


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 31/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Faron Pharmaceuticals Oy- 1.79
FTSE AIM All Share+ 0.35
More...

Company profile

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested in several Phase III studies around the world against COVID-19.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202402:16:061351013.50
28/03/202402:16:06140208291.20
28/03/202402:16:061355472.90
28/03/202411:46:58137.5925,00034,397.50
28/03/202401:20:5513779.59

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.